The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial.
Angela M ReiersenCaline MattarRachel Bender IgnacioDavid R BoulwareTodd C LeeRachel HessAlexander J LankowskiEmily Gibson McDonaldJ Phillip MillerWilliam G PowderlyMatthew Flinn PullenJeffrey T RadoMichael W RichJoshua T SchifferJulie SchweigerAdam M SpivakAngela StevensSimone N VigodPayal AgarwalLei YangMichael YinglingTorie R GettingerCharles F ZorumskiEric J LenzePublished in: Open forum infectious diseases (2023)
ClinicalTrials.gov Identifier: NCT04668950.